Related Experiment Video
Updated: May 28, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
p53 regulates the expression of human angiotensin II AT(2) receptor interacting protein (ATIP1) gene
Zujian Chen1, Xiqiang Liu, Cheng Wang
1Center for Molecular Biology of Oral Diseases, College of Dentistry, University of Illinois at Chicago, Chicago, IL, USA.
Abstract:
Angiotensin II AT(2) receptor interacting protein 1 (ATIP1) has been recently identified as a tumor suppressor. In the present study, a 2.2 kb fragment of the 5' flanking region of the human ATIP1 gene was cloned, and its promoter activity was confirmed. Two putative p53 binding sites were identified in the minimal promoter. Cisplatin treatment and ectopic expression of p53 led to enhanced ATIP1 expression. Knockdown of p53 reduced the ATIP1 expression. The direct interaction of p53 and the ATIP1 promoter was confirmed by reporter gene and chromatin-immunoprecipitation assays. When the p53 sites were mutated, the effect of p53 on ATIP1 promoter was eliminated. The results suggest that the ATIP1 gene is regulated by p53 at the transcriptional level, and that it may play an important role in cancer initiation and progression.
Insights
The tumor suppressor Angiotensin II AT(2) receptor interacting protein 1 (ATIP1) is regulated by the p53 protein. p53 directly binds to the ATIP1 promoter, influencing its expression and impacting cancer progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Angiotensin II AT(2) receptor interacting protein 1 (ATIP1) is recognized as a tumor suppressor.
- Understanding the regulatory mechanisms of ATIP1 is crucial for cancer research.
Purpose of the Study:
- To investigate the transcriptional regulation of the human ATIP1 gene.
- To determine the role of the p53 protein in controlling ATIP1 expression.
Main Methods:
- Cloning and promoter activity assay of the 5' flanking region of the ATIP1 gene.
- Identification of p53 binding sites within the ATIP1 promoter.
- Reporter gene assays and chromatin-immunoprecipitation to confirm p53-ATIP1 promoter interaction.
- p53 knockdown and mutation studies to assess functional impact.
Main Results:
- A 2.2 kb fragment of the ATIP1 5' flanking region demonstrated promoter activity.
- Two putative p53 binding sites were identified in the minimal ATIP1 promoter.
- p53 significantly enhanced ATIP1 expression, while p53 knockdown reduced it.
- Direct binding of p53 to the ATIP1 promoter was confirmed, and mutation of these sites abolished p53's regulatory effect.
Conclusions:
- The ATIP1 gene is transcriptionally regulated by the p53 protein.
- p53 plays a significant role in modulating ATIP1 expression.
- ATIP1, regulated by p53, may be important in cancer initiation and progression.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Antihypertensive Drugs: Direct Renin Inhibitors
